Showing a limited preview of this publication:
Clinical drug trials are public goods and should be publicly funded to avoid undersupply, the suppression of adverse results and other problems, according to Tracy R. Lewis, Jerome H. Reichman and Anthony D. So.
Published Online: 2007-1-19
©2011 Walter de Gruyter GmbH & Co. KG, Berlin/Boston